---
document_datetime: 2023-09-21 19:12:23
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cubicin-epar-all-authorised-presentations_en.pdf
document_name: cubicin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9543374
conversion_datetime: 2025-12-22 07:36:22.138479
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form                           | Route of Administration   | Packaging    | Content           | Package size   |
|-----------------|-----------------|------------|-----------------------------------------------|---------------------------|--------------|-------------------|----------------|
| EU/1/05/328/001 | Cubicin         | 350 mg     | Powder for solution for injection or infusion | Intravenous use           | vial (glass) | 350 mg (50 mg/ml) | 1 vial         |
| EU/1/05/328/002 | Cubicin         | 500 mg     | Powder for solution for injection or infusion | Intravenous use           | vial (glass) | 500 mg (50 mg/ml) | 1 vial         |
| EU/1/05/328/003 | Cubicin         | 350 mg     | Powder for solution for injection or infusion | Intravenous use           | vial (glass) | 350 mg (50 mg/ml) | 5 vials        |
| EU/1/05/328/004 | Cubicin         | 500 mg     | Powder for solution for injection or infusion | Intravenous use           | vial (glass) | 500 mg (50 mg/ml) | 5 vials        |